new glp 1 drugs in development GLP-1R Agonists for Weight Loss GLP Agonist Clinical Trial Pipeline

When Zepbound (Tirzepatide) is taken with insulin and the insulin dose is reduced too quickly, it can lead to high blood sugar (hyperglycemia), which increases the risk of diabetic ketoacidosis

Treatment of type 1 diabetic patients with glucagon-like peptide-1 (GLP-1) and GLP-1R agonists

Nonetheless, these animal models remain valuable research tools for elucidating the mechanistic underpinnings of the disease [77, 78]

For support managing GLP-1 side effects and staying on track with your blood sugar or weight management goals, consider working with a GI provider, such as the team at Oshi Health

A healthy gut produces short chain fatty acids that stimulate GLP release

In all of these situations, continued use should always be discussed with a doctor